BioSyent (CVE:RX) Shares Break Below Fifty Day Moving Average – Should You Sell?

BioSyent Inc. (CVE:RX) passed below its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of C$15.93 and traded as low as C$14.75. BioSyent shares last traded at C$15.97, with a volume of 27,732 shares trading hands.

BioSyent Trading Down 6.9%

The company has a debt-to-equity ratio of 6.85, a quick ratio of 6.91 and a current ratio of 2.07. The business has a 50-day simple moving average of C$15.93 and a two-hundred day simple moving average of C$14.97. The stock has a market cap of C$179.38 million, a price-to-earnings ratio of 18.70 and a beta of 1.05.

Insider Activity at BioSyent

In other news, Director Seyed Ahmad Ashrafi sold 2,900 shares of the business’s stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of C$16.55, for a total value of C$47,995.00. Following the sale, the director owned 21,461 shares of the company’s stock, valued at C$355,179.55. The trade was a 11.90% decrease in their ownership of the stock. Insiders have sold a total of 7,251 shares of company stock valued at $118,207 over the last 90 days. Insiders own 33.65% of the company’s stock.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis.